These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 176660)

  • 1. Androgen insensitivity in man: evidence for genetic heterogeneity.
    Amrhein JA; Meyer WJ; Jones HW; Migeon CJ
    Proc Natl Acad Sci U S A; 1976 Mar; 73(3):891-4. PubMed ID: 176660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Partial androgen insensitivity: the Reifenstein syndrome revisited.
    Amrhein JA; Klingensmith GJ; Walsh PC; McKusick VA; Migeon CJ
    N Engl J Med; 1977 Aug; 297(7):350-6. PubMed ID: 876326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic regulation of the androgen receptor--a study of testicular feminization in the mouse.
    Bardin CW; Bullock LP; Jänne O; Jacob ST
    J Steroid Biochem; 1975; 6(3-4):515-20. PubMed ID: 171503
    [No Abstract]   [Full Text] [Related]  

  • 4. Phenotypic variation in a family with partial androgen insensitivity syndrome explained by differences in 5alpha dihydrotestosterone availability.
    Boehmer AL; Brinkmann AO; Nijman RM; Verleun-Mooijman MC; de Ruiter P; Niermeijer MF; Drop SL
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1240-6. PubMed ID: 11238515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complete androgen insensitivity with a normal amount of 5 alpha-dihydrotestosterone-binding activity in labium majus skin fibroblasts.
    Kaufman M; Pinsky L; Baird PA; McGillivray BC
    Am J Med Genet; 1979; 4(4):401-11. PubMed ID: 575468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human complete androgen insensitivity with normal dihydrotestosterone receptor binding capacity in cultured genital skin fibroblasts: evidence for a qualitative abnormality of the receptor.
    Brown TR; Maes M; Rothwell SW; Migeon CJ
    J Clin Endocrinol Metab; 1982 Jul; 55(1):61-9. PubMed ID: 7076808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complete androgen insensitivity syndrome characterized by increased concentration of a normal androgen receptor in genital skin fibroblasts.
    Hughes IA; Evans BA
    J Clin Endocrinol Metab; 1986 Aug; 63(2):309-15. PubMed ID: 3088020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DHT-receptor in cultured human fibroblasts: binding study in a family with androgen insensitivity (complete testicular feminisation).
    Donti E; Nicoletti I; Filipponi P; Venti G; Bocchini V; Santeusanio F
    J Med Genet; 1982 Oct; 19(5):349-53. PubMed ID: 7143388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amino acid substitutions in the hormone-binding domain of the human androgen receptor alter the stability of the hormone receptor complex.
    Marcelli M; Zoppi S; Wilson CM; Griffin JE; McPhaul MJ
    J Clin Invest; 1994 Oct; 94(4):1642-50. PubMed ID: 7929841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid detection of a mutation hot-spot in the human androgen receptor.
    Malmgren H; Gustavsson J; Tuvemo T; Dahl N
    Clin Genet; 1996 Oct; 50(4):202-5. PubMed ID: 9001799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single nucleotide substitution of the androgen receptor gene in a case with receptor-positive androgen insensitivity syndrome (complete form).
    Kasumi H; Komori S; Yamasaki N; Shima H; Isojima S
    Acta Endocrinol (Copenh); 1993 Apr; 128(4):355-60. PubMed ID: 8498155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substitution of valine-865 by methionine or leucine in the human androgen receptor causes complete or partial androgen insensitivity, respectively with distinct androgen receptor phenotypes.
    Kazemi-Esfarjani P; Beitel LK; Trifiro M; Kaufman M; Rennie P; Sheppard P; Matusik R; Pinsky L
    Mol Endocrinol; 1993 Jan; 7(1):37-46. PubMed ID: 8446106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carrier detection in the testicular feminisation syndrome: deficient 5 alpha-dihydrotestosterone binding in cultured skin fibroblasts from the mothers of patients with complete androgen insensitivity.
    Hodgins MB; Duke EM; Ring D
    J Med Genet; 1984 Jun; 21(3):178-81. PubMed ID: 6748013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Locus on human X chromosome for dihydrotestosterone receptor and androgen insensitivity.
    Meyer WJ; Migeon BR; Migeon CJ
    Proc Natl Acad Sci U S A; 1975 Apr; 72(4):1469-72. PubMed ID: 165510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dihydrotestosterone induces minor transcriptional alterations in genital skin fibroblasts of children with and without androgen insensitivity.
    Tanase-Nakao K; Mizuno K; Hayashi Y; Kojima Y; Hara M; Matsumoto K; Matsubara Y; Igarashi M; Miyado M; Fukami M
    Endocr J; 2019 Apr; 66(4):387-393. PubMed ID: 30787207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Testicular feminization associated with a thermolabile androgen receptor in culutred human fibroblasts.
    Griffin JE
    J Clin Invest; 1979 Dec; 64(6):1624-31. PubMed ID: 500829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Androgen metabolism and receptor activity in preputial glands and kidneys of normal and androgen-insenitive tfm rats and tfm/y mice.
    Bardin CW; Bullock LP; Mowszowicz I
    Methods Enzymol; 1975; 39():454-60. PubMed ID: 168470
    [No Abstract]   [Full Text] [Related]  

  • 18. Incomplete androgen insensitivity associated with a thermolabile androgen receptor.
    Hasegawa T; Imasaki K; Haji M; Hasegawa Y; Aso T; Koto S; Tsuchiya Y; Kawamura T; Shinohara O; Nawata H
    Endocr J; 1994 Feb; 41(1):31-5. PubMed ID: 7951549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Androgen receptors in the anterior pituitary and central nervous system of the androgen "insensitive" (Tfm) rat: correlation between receptor binding and effects of androgens on gonadotropin secretion.
    Naess O; Haug E; Attramadal A; Aakvaag A; Hansson V; French F
    Endocrinology; 1976 Nov; 99(5):1295-303. PubMed ID: 991822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defective androgen action at the cellular level in the androgen resistance syndromes. I. Differences between the complete and incomplete testicular feminization syndromes.
    Medina M; Chávez B; Pérez-Palacios G
    J Clin Endocrinol Metab; 1981 Dec; 53(6):1243-6. PubMed ID: 7298803
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.